2013
DOI: 10.1007/s11886-013-0409-8
|View full text |Cite
|
Sign up to set email alerts
|

Renal Artery Stenosis: Medical Versus Interventional Therapy

Abstract: Reports from recent trials indicate little additional benefit from stent supported revascularization in patients with atherosclerotic renal artery stenosis. These data have been questioned, particularly on the basis of including subjects with modest occlusive disease and reports of clinical benefits to patients with episodic congestive heart failure. Nonetheless, these data have moved the pendulum away from renal revascularization as a primary maneuver to one reserved for refractory hypertension and/or progres… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 42 publications
0
2
0
1
Order By: Relevance
“…Dès lors, il apparaît souhaitable de sélectionner très strictement les patients âgés candidats à l'angioplastie. Les patients avec des tableaux d'oedèmes pulmonaires répétés, d'angor instable lié à des pics tensionnels, de dégradation rapide de la fonction rénale ou de sténose artérielle à haut risque de thrombose (surtout sur rein unique) paraissent être ceux qui tirent profit de la revascularisation [44].…”
Section: Sténose Artérielle Rénale Et Néphropathie Ischémiqueunclassified
“…Dès lors, il apparaît souhaitable de sélectionner très strictement les patients âgés candidats à l'angioplastie. Les patients avec des tableaux d'oedèmes pulmonaires répétés, d'angor instable lié à des pics tensionnels, de dégradation rapide de la fonction rénale ou de sténose artérielle à haut risque de thrombose (surtout sur rein unique) paraissent être ceux qui tirent profit de la revascularisation [44].…”
Section: Sténose Artérielle Rénale Et Néphropathie Ischémiqueunclassified
“…96 Mesenchymal stem cell therapies for various types of kidney injuries have been the subject of research in many preclinical and clinical studies, most of them focusing on acute kidney injury. [97][98][99][100] The repair mechanism of mesenchymal stem cells (MSC) includes cytokine release and MSC differentiation into renal cells; MSC can be implanted intravenously, intra-arterially, or within the kidney parenchyma. 101 Ischemic chronic kidney disease caused by renal artery stenosis is characterized by glomerular fibrosis and decreased number of microvessels, with secondary triggering of the renin angiotensin aldosterone cascade, with subsequent vasoconstriction, inflammation and fibrosis.…”
Section: Renal Ischemiamentioning
confidence: 99%
“…On the other hand, if BP control cannot be achieved or the patient experiences progressive loss of kidney function, recurrent and refractory congestive heart failure, pulmonary edema, or unstable angina that is attributable to rapid BP rising, then further imaging studies with intent to correct the renal artery stenosis (RAS) are justified. 76 A range of radiological imaging techniques are clinically available for RAS evaluation. 77 Duplex Doppler This low-power view shows an interlobular artery with marked mucoid intimal edema.…”
Section: Ischemic Nephropathy Associated With Renovascular Diseasesmentioning
confidence: 99%